Morgan Stanley
CLBT icon

Morgan Stanley’s Cellebrite CLBT Stock Holding History

Morgan Stanley’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32M Buy
2,193,732
+112,679
+5% +$1.49M ﹤0.01% 2662
2026
Q1 		$28.7M Sell
2,081,053
-309,061
-13% -$4.66M ﹤0.01% 2618
2025
Q4 		$43.1M Sell
2,390,114
-492,232
-17% -$8.84M ﹤0.01% 2224
2025
Q3 		$53.4M Sell
2,882,346
-1,770,232
-38% -$27.8M ﹤0.01% 1953
2025
Q2 		$74.4M Buy
4,652,578
+689,319
+17% +$12.3M ﹤0.01% 1566
2025
Q1 		$77M Sell
3,963,259
-1,199,548
-23% -$25.2M 0.01% 1438
2024
Q4 		$114M Sell
5,162,807
-212,583
-4% -$4.09M 0.01% 1163
2024
Q3 		$90.5M Sell
5,375,390
-1,615,681
-23% -$24M 0.01% 1325
2024
Q2 		$83.5M Buy
6,991,071
+2,866,806
+70% +$32M 0.01% 1310
2024
Q1 		$45.7M Buy
4,124,265
+512,894
+14% +$5.23M ﹤0.01% 1843
2023
Q4 		$31.3M Buy
3,611,371
+1,276,478
+55% +$9.92M ﹤0.01% 2218
2023
Q3 		$17.9M Buy
2,334,893
+178,058
+8% +$1.34M ﹤0.01% 2577
2023
Q2 		$15.5M Buy
2,156,835
+38,330
+2% +$223K ﹤0.01% 2731
2023
Q1 		$12.9M Sell
2,118,505
-26,379
-1% -$143K ﹤0.01% 2895
2022
Q4 		$9.35M Buy
2,144,884
+2,140,900
+53,737% +$9.56M ﹤0.01% 3156
2022
Q3 		$15K Sell
3,984
-2,310
-37% -$11.6K ﹤0.01% 6914
2022
Q2 		$31K Buy
6,294
+69
+1% +$359 ﹤0.01% 6820
2022
Q1 		$40K Sell
6,225
-12,725
-67% -$84.4K ﹤0.01% 6800
2021
Q4 		$152K Buy
18,950
+12,617
+199% +$119K ﹤0.01% 6206
2021
Q3 		$58K Buy
+6,333
New +$66.2K ﹤0.01% 6646

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Morgan Stanley's CLBT Position: Q2 2026 in Review

Morgan Stanley increased its Cellebrite (CLBT) stake by 5.4% in Q2 2026, buying an estimated $1.49M and bringing the position to 2,193,732 shares worth $32M. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

Morgan Stanley first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $114M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Morgan Stanley held 2,193,732 shares of Cellebrite worth $32M as of Q2 2026.
  • Morgan Stanley bought 112,679 Cellebrite shares in Q2 2026, an estimated $1.49M.
  • Cellebrite made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2662 holding.
  • Morgan Stanley first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Cellebrite position peaked at $114M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.